Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trialBruno François, Pierre‐François Laterre, Thierry Dugernier et al.|Intensive Care Medicine|2020Cited by 71
Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trialBruno François, Pierre‐François Laterre, Simon Lambden et al.|BMJ Open|2021Cited by 20